Design and development of novel Mycobacterium tuberculosis l-alanine dehydrogenase inhibitors

European Journal of Medicinal Chemistry
2015.0

Abstract

In the present study, we used crystal structure of MTB L-AlaDH protein complex with N6-methyl adenosine for structure based virtual screening of in house database to identify new small molecule inhibitors for MTB-L-AlaDH. Two molecules identified as better leads and were modified synthetically to obtain thirty novel analogues belonging to 2-iminothiazolidine-4-ones and 4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamides. Among the screened compounds four (4n, 4o, 12 and 14) emerged as potent inhibitors displaying IC50 values ranging from 0.58 ± 0.02 to 1.74 ± 0.03 μM against MTB-L-AlaDH and were non-cytotoxic at 50 μM. Some of these synthesized compounds also exhibited good activity against nutrient starved dormant MTB cells. The most potent inhibitors were found to stabilize the protein which was confirmed biophysically through differential scanning fluorimetry.

Knowledge Graph

Similar Paper

Design and development of novel Mycobacterium tuberculosis l-alanine dehydrogenase inhibitors
European Journal of Medicinal Chemistry 2015.0
Design and development of new class of Mycobacterium tuberculosis l-alanine dehydrogenase inhibitors
Bioorganic & Medicinal Chemistry 2016.0
Identification and development of 2-methylimidazo[1,2-a]pyridine-3-carboxamides as Mycobacterium tuberculosis pantothenate synthetase inhibitors
Bioorganic & Medicinal Chemistry 2014.0
Development of novel tetrahydrothieno[2,3-c]pyridine-3-carboxamide based Mycobacterium tuberculosis pantothenate synthetase inhibitors: Molecular hybridization from known antimycobacterial leads
Bioorganic & Medicinal Chemistry 2014.0
Mycobacterium tuberculosis lysine-ɛ-aminotransferase a potential target in dormancy: Benzothiazole based inhibitors
Bioorganic & Medicinal Chemistry 2017.0
Development of benzo[d]oxazol-2(3H)-ones derivatives as novel inhibitors of Mycobacterium tuberculosis InhA
Bioorganic & Medicinal Chemistry 2014.0
2-(2-Hydrazinyl)thiazole derivatives: Design, synthesis and in vitro antimycobacterial studies
European Journal of Medicinal Chemistry 2013.0
Design and Synthesis of a Focused Library of Diamino Triazines as Potential Mycobacterium tuberculosis DHFR Inhibitors
ACS Medicinal Chemistry Letters 2015.0
Design and development of ((4-methoxyphenyl)carbamoyl) (5-(5-nitrothiophen-2-yl)-1,3,4-thiadiazol-2-yl)amide analogues as Mycobacterium tuberculosis ketol-acid reductoisomerase inhibitors
European Journal of Medicinal Chemistry 2020.0
Design and synthesis of 11α-substituted bile acid derivatives as potential anti-tuberculosis agents
Bioorganic & Medicinal Chemistry Letters 2015.0